Pharmacy Access Improves Rabies Vaccine Completion Rates

Patients completing the four-dose rabies series see higher adherence rates when utilizing community pharmacy follow-ups.

Updated on Oct. 27, 2026 in COVID-19

Pharmacy Access Improves Rabies Vaccine Completion Rates

Live Poll

Would you trust a local pharmacy to administer critical multi-dose medical treatments instead of a hospital?

Expanding rabies vaccine access to community pharmacies significantly improved series completion rates for patients in the Appalachian Highlands. This model could offer a new approach to managing the 100,000 post-exposure treatments provided annually in the United States.

Why it matters

Patients often struggle to complete the required four-dose rabies vaccine series due to the logistical burden of multiple hospital visits. By decentralizing follow-up care from emergency departments, health systems may better ensure patients finish the life-saving regimen.

A study of 367 patients in the Appalachian Highlands found that offering pharmacy-based follow-up doses improved overall series completion from 49.6% to 53.1%. While 80% of those using pharmacies completed the four-dose series, it is unknown how this model scales nationally.

The players

American Journal of Infection Control

A peer-reviewed publication focusing on infection prevention and public health research.

The details

The standard rabies post-exposure series requires four doses administered on day zero, day three, day seven, and day 14. Emergency departments typically manage the initial dose but often lack the specialized scheduling infrastructure to ensure patients return for subsequent shots. Allowing community pharmacies to administer follow-up doses simplifies the process, reducing the burden on patients and hospital systems that are currently the primary point of care for the 100,000 residents receiving prophylaxis each year.

2026: Animal rabies cases and human exposures increased in the United States.
October 26, 2026: The study was published in the American Journal of Infection Control.

Allergies
Oct. 23
Lyme Disease Lifetime Risk Varies By State
Allergies
Oct. 24
Flu Vaccine Linked to Lower Severe Illness in Study
COVID-19
Oct. 26
Vaccine Insurance Coverage Faces Delays

Health Landscape

Managing the 100,000 annual rabies post-exposure treatments requires a high degree of patient adherence to prevent potential infections. This shift toward pharmacy-based follow-up represents an evolution in public health delivery aimed at reducing the logistical friction common in emergency care.

If you are prescribed a multi-dose vaccine series, ask your healthcare provider if follow-up doses can be managed at a local pharmacy. Completing the full series is critical, so discussing your options for reducing scheduling conflicts with your physician is a vital step in your care.

The takeaway

Maintaining strict adherence to the four-dose rabies schedule is essential for protecting your health after exposure. If you are required to start this series, consult your physician about whether your health system allows for pharmacy-based follow-up to help you manage the treatment timeline.